Brenda J. Bradley
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Association of Fructosamine Levels With Glycemic Management in Children With Type 1 Diabetes as Determined by Continuous Glucose Monitoring: Results From the CGM TIME Trial.
Journal: Canadian journal of diabetes
Published: September 24, 2023
Motivational Stage at Continuous Glucose Monitoring (CGM) Initiation in Pediatric Type 1 Diabetes Is Associated With Current Glycemic Control but Does Not Predict Future CGM Adherence or Glycemic Control.
Journal: Canadian journal of diabetes
Published: December 15, 2020
Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial.
Journal: Pediatric diabetes
Published: September 07, 2020
Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial.
Journal: Pediatric diabetes
Published: July 09, 2020
Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 31, 2019
Identification of Hybrid Insulin Peptides (HIPs) in Mouse and Human Islets by Mass Spectrometry.
Journal: Journal of proteome research
Published: December 27, 2018
CD11c+ Cells Are Gatekeepers for Lymphocyte Trafficking to Infiltrated Islets During Type 1 Diabetes.
Journal: Frontiers in immunology
Published: October 25, 2018
An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse.
Journal: Journal of autoimmunity
Published: August 16, 2016
Last Updated: 09/26/2026